Globus Medical (GMED) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US3795772082
Globus Medical, Inc. is a renowned medical device company that focuses on developing and delivering healthcare solutions for individuals suffering from musculoskeletal disorders, both in the United States and across the globe.
The company specializes in a wide range of spine products, catering to various conditions such as degenerative issues, congenital disorders, deformities, tumors, and trauma injuries. These products include pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices.
Moreover, Globus Medical provides innovative treatment options for motion preservation technologies, interventional pain management solutions, as well as regenerative biologic products like allografts and synthetic alternatives.
Additionally, they offer orthopedic trauma products such as fracture plates, compression screws, intramedullary nails, and external fixation systems, along with hip and knee joint solutions including modular hip stems, acetabular cups, and knee arthroplasty implants.
Established in 2003, Globus Medical, Inc. is headquartered in Audubon, Pennsylvania, and continues to expand its product offerings to enhance the quality of life for patients worldwide. To learn more, visit their website at https://www.globusmedical.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
GMED Stock Overview
Market Cap in USD | 7,371m |
Sector | Healthcare |
Industry | Medical Devices |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 2012-08-03 |
GMED Stock Ratings
Fundamental | 2.62 |
Dividend | - |
Growth 5y | 0.46 |
Rel. Performance vs Sector | -1.74 |
Analysts | 3.53/5 |
Fair Price Momentum | 48.00 USD |
Fair Price DCF | 40.10 USD |
GMED Dividends
Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
GMED Growth Ratios
Growth 12m | -0.77% |
Growth Correlation 12m | -36% |
Growth Correlation 3m | -13% |
CAGR 5y | 1.85% |
Sharpe Ratio 12m | -0.22 |
Alpha vs SP500 12m | -29.93 |
Beta vs SP500 5y weekly | 0.89 |
ValueRay RSI | 48.47 |
Volatility GJR Garch 1y | 36.38% |
Price / SMA 50 | -1.19% |
Price / SMA 200 | -0.19% |
Current Volume | 874.4k |
Average Volume 20d | 1075.5k |
External Links for GMED Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of March 29, 2024, the stock is trading at USD 53.06 with a total of 874,390 shares traded.
Over the past week, the price has changed by +2.37%, over one month by -5.97%, over three months by -0.19% and over the past year by -0.58%.
According to ValueRays Forecast Model, GMED Globus Medical will be worth about 53.2 in March 2025. The stock is currently trading at 53.06. This means that the stock has a potential upside of +0.23%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 61.6 | 16.1% |
Analysts Target Price | 67.3 | 26.7% |
ValueRay Target Price | 53.2 | 0.23% |